BACKGROUND: Cognitive impairment still occurs in a substantial subset of HIV-infected patients, despite effective viral suppression with highly active antiretroviral therapy (HAART). Structural brain changes may provide clues about the underlying pathophysiology. This study provides a detailed spatial characterization of the pattern and extent of brain volume changes associated with HIV and relates these brain measures to cognitive ability and clinical variables. METHODS: Multiple novel neuroimaging techniques (deformation-based morphometry, voxel-based morphometry, and cortical modeling) were used to assess regional brain volumes in 125 HIV-infected patients and 62 HIV-uninfected individuals. Ninety percent of the HIV-infected patients were on stable HAART with most of them (75%) having plasma viral suppression. Brain volumetrics and cortical thickness estimates were compared between the HIV-infected and uninfected groups, and the relationships between these measures of brain volume and indices of current and past infection severity, central nervous system penetration of HAART, and cognitive performance were assessed. RESULTS: Regionally specific patterns of reduced thalamic and brainstem volumes and reduced cortical thickness in the orbitofrontal cortex, cingulate gyrus, primary motor and sensory cortex, temporal, and frontal lobes were seen in HIV-infected patients compared to HIV-uninfected participants. Observed white matter loss and subcortical atrophy were associated with lower nadir CD4 cell counts, while reduction in cortical thickness was related to worse cognitive performance. CONCLUSIONS: Our findings suggest that distinct mechanisms may underlie cortical and subcortical injury in people with HIV and argues for the potential importance of early initiation of HAART to protect long-term brain health.
BACKGROUND:Cognitive impairment still occurs in a substantial subset of HIV-infectedpatients, despite effective viral suppression with highly active antiretroviral therapy (HAART). Structural brain changes may provide clues about the underlying pathophysiology. This study provides a detailed spatial characterization of the pattern and extent of brain volume changes associated with HIV and relates these brain measures to cognitive ability and clinical variables. METHODS: Multiple novel neuroimaging techniques (deformation-based morphometry, voxel-based morphometry, and cortical modeling) were used to assess regional brain volumes in 125 HIV-infectedpatients and 62 HIV-uninfected individuals. Ninety percent of the HIV-infectedpatients were on stable HAART with most of them (75%) having plasma viral suppression. Brain volumetrics and cortical thickness estimates were compared between the HIV-infected and uninfected groups, and the relationships between these measures of brain volume and indices of current and past infection severity, central nervous system penetration of HAART, and cognitive performance were assessed. RESULTS: Regionally specific patterns of reduced thalamic and brainstem volumes and reduced cortical thickness in the orbitofrontal cortex, cingulate gyrus, primary motor and sensory cortex, temporal, and frontal lobes were seen in HIV-infectedpatients compared to HIV-uninfectedparticipants. Observed white matter loss and subcortical atrophy were associated with lower nadirCD4 cell counts, while reduction in cortical thickness was related to worse cognitive performance. CONCLUSIONS: Our findings suggest that distinct mechanisms may underlie cortical and subcortical injury in people with HIV and argues for the potential importance of early initiation of HAART to protect long-term brain health.
Authors: Ronald A Cohen; Jaroslaw Harezlak; Giovanni Schifitto; George Hana; Uraina Clark; Assawin Gongvatana; Robert Paul; Michael Taylor; Paul Thompson; Jeffery Alger; Mark Brown; Jianhui Zhong; Thomas Campbell; Elyse Singer; Eric Daar; Deborah McMahon; Yuen Tso; Constantin T Yiannoutsos; Bradford Navia Journal: J Neurovirol Date: 2010-02 Impact factor: 2.643
Authors: R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant Journal: Neurology Date: 2010-12-07 Impact factor: 9.910
Authors: Adolf Pfefferbaum; Margaret J Rosenbloom; Stephanie A Sassoon; Carol A Kemper; Stanley Deresinski; Torsten Rohlfing; Edith V Sullivan Journal: Biol Psychiatry Date: 2012-03-27 Impact factor: 13.382
Authors: James T Becker; Victoria Maruca; Lawrence A Kingsley; Joanne M Sanders; Jeffery R Alger; Peter B Barker; Karl Goodkin; Eileen Martin; Eric N Miller; Ann Ragin; Ned Sacktor; Ola Selnes Journal: Neuroradiology Date: 2011-03-22 Impact factor: 2.804
Authors: Paul M Thompson; Rebecca A Dutton; Kiralee M Hayashi; Arthur W Toga; Oscar L Lopez; Howard J Aizenstein; James T Becker Journal: Proc Natl Acad Sci U S A Date: 2005-10-14 Impact factor: 11.205
Authors: David J Moore; Eliezer Masliah; Julie D Rippeth; Raul Gonzalez; Catherine L Carey; Mariana Cherner; Ronald J Ellis; Cristian L Achim; Thomas D Marcotte; Robert K Heaton; Igor Grant Journal: AIDS Date: 2006-04-04 Impact factor: 4.177
Authors: Marloes A M Janssen; Olga Meulenbroek; Stefan C A Steens; Bozena Góraj; Marjolein Bosch; Peter P Koopmans; Roy P C Kessels Journal: AIDS Date: 2015-10-23 Impact factor: 4.177
Authors: Ryan P Bell; Laura L Barnes; Sheri L Towe; Nan-Kuei Chen; Allen W Song; Christina S Meade Journal: J Neurovirol Date: 2018-04-23 Impact factor: 2.643